FDA Approves Expanded Uses for GARDASIL in Preventing Cancer

Tags:: Merck Gardasil HPV Vaginal Cancer Vulvar Cervical Genitals Warts Supplemental Biologics License

Edit Video Details

By: NewsInfusion
Subscribers: 3
Updated: 07-Dec-09
Videos: 202

International
Comments: 0
Views: 238
Added: 17-Sep-08

September 12, 2008 – The U.S. Food and Drug Administration today announced the approval of the vaccine GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] for the prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26. These two HPV types cause 70 percent of cervical cancers, and are known to also cause some vulvar and vaginal cancers, but the percentages are not well defined.